250 related articles for article (PubMed ID: 30771682)
1. SELDI-TOF MS Analysis of Hepatocellular Carcinoma in an Australian Cohort.
Schlichtemeier SM; Nahm CB; Xue A; Gill AJ; Smith RC; Hugh TJ
J Surg Res; 2019 Jun; 238():127-136. PubMed ID: 30771682
[TBL] [Abstract][Full Text] [Related]
2. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
[TBL] [Abstract][Full Text] [Related]
3. A pre-operative clinical model to predict microvascular invasion and long-term outcome after resection of hepatocellular cancer: The Australian experience.
Schlichtemeier SM; Pang TC; Williams NE; Gill AJ; Smith RC; Samra JS; Lam VW; Hollands M; Richardson AJ; Pleass HC; Nozawa S; Albania M; Hugh TJ
Eur J Surg Oncol; 2016 Oct; 42(10):1576-83. PubMed ID: 27378158
[TBL] [Abstract][Full Text] [Related]
4. A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma.
Banerjee S; Wang DS; Kim HJ; Sirlin CB; Chan MG; Korn RL; Rutman AM; Siripongsakun S; Lu D; Imanbayev G; Kuo MD
Hepatology; 2015 Sep; 62(3):792-800. PubMed ID: 25930992
[TBL] [Abstract][Full Text] [Related]
5. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
6. Preoperative predictors of microvascular invasion in multinodular hepatocellular carcinoma.
Zhao WC; Fan LF; Yang N; Zhang HB; Chen BD; Yang GS
Eur J Surg Oncol; 2013 Aug; 39(8):858-64. PubMed ID: 23669199
[TBL] [Abstract][Full Text] [Related]
7. Nomogram to Assist in Surgical Plan for Hepatocellular Carcinoma: a Prediction Model for Microvascular Invasion.
Lin S; Ye F; Rong W; Song Y; Wu F; Liu Y; Zheng Y; Siqin T; Zhang K; Wang L; Wu J
J Gastrointest Surg; 2019 Dec; 23(12):2372-2382. PubMed ID: 30820799
[TBL] [Abstract][Full Text] [Related]
8. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma.
Wang L; Jin YX; Ji YZ; Mu Y; Zhang SC; Pan SY
World J Gastroenterol; 2020 Apr; 26(14):1647-1659. PubMed ID: 32327913
[TBL] [Abstract][Full Text] [Related]
10. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
Sumie S; Kuromatsu R; Okuda K; Ando E; Takata A; Fukushima N; Watanabe Y; Kojiro M; Sata M
Ann Surg Oncol; 2008 May; 15(5):1375-82. PubMed ID: 18324443
[TBL] [Abstract][Full Text] [Related]
11. Predicting early intrahepatic recurrence of hepatocellular carcinoma after microwave ablation using SELDI-TOF proteomic signature.
Cao XL; Li H; Yu XL; Liang P; Dong BW; Fan J; Li M; Liu FY
PLoS One; 2013; 8(12):e82448. PubMed ID: 24349287
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of microvascular invasion in early-intermediate stage hepatocelluar carcinoma: a propensity score matching analysis.
Shen J; Wen J; Li C; Wen T; Yan L; Li B; Yang J; Lu C
BMC Cancer; 2018 Mar; 18(1):278. PubMed ID: 29530006
[TBL] [Abstract][Full Text] [Related]
15. A new laboratory-based algorithm to predict microvascular invasion and survival in patients with hepatocellular carcinoma.
Zhu Y; Xu D; Zhang Z; Dong J; Zhou Y; Zhang WW; Hong L; Zhu WW
Int J Surg; 2018 Sep; 57():45-53. PubMed ID: 30075291
[TBL] [Abstract][Full Text] [Related]
16. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.
Han J; Li ZL; Xing H; Wu H; Zhu P; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Wu MC; Shen F; Yang T
HPB (Oxford); 2019 Aug; 21(8):962-971. PubMed ID: 30718183
[TBL] [Abstract][Full Text] [Related]
17. Microvascular invasion patterns affect survival in hepatocellular carcinoma patients after second hepatectomy.
Hou YF; Wei YG; Yang JY; Wen TF; Xu MQ; Yan LN; Li B; Chen KF
J Surg Res; 2016 Jan; 200(1):82-90. PubMed ID: 26259778
[TBL] [Abstract][Full Text] [Related]
18. Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.
Wang L; Wang W; Rong W; Li Z; Wu F; Liu Y; Zheng Y; Zhang K; Siqin T; Liu M; Chen B; Wu J
BMC Cancer; 2020 Jul; 20(1):614. PubMed ID: 32611327
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes after curative resection for patients with macroscopically solitary hepatocellular carcinoma without macrovascular invasion and an analysis of prognostic factors.
Li SH; Wei W; Guo RP; Shi M; Guo ZX; Chen ZY; Xiao CZ; Cai MY; Zheng L
Med Oncol; 2013 Dec; 30(4):696. PubMed ID: 23975633
[TBL] [Abstract][Full Text] [Related]
20. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
